Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Efficacy of Low- vs High-Activity Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer
TCTR20260313002Phase 3Completed
- Sponsor
- Prapokklao Hospital
- Start
- Sep 2005
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
A Phase 3 trial of iodine-131 in well-differentiated thyroid cancer (WDTC), sponsored by Prapokklao Hospital. Started Sep 2005; status: completed.
02
Drugs
iodine-131
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on TCTR20260313002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260313002.